Earnings report for Invitae Corporation (NYSE:NVTA) is anticipated on May, 8., RTT reports. The EPS diference is $0.17 or 25.76 % up from last years number. Previous year: $-0.66; Analysts forcast: $-0.49. Analysts at Wall Street see Invitae Corporation’s 22.50 % negative EPS growth compared to $-0.40 EPS for last quarter. The stock decreased 4.17% or $1.09 during the last trading session, touching $25.05.Invitae Corporation has volume of 1.67 million shares. Since April 16, 2018 NVTA has risen 199.71% and is uptrending. NVTA outperformed by 195.34% the S&P500.

Invitae Corporation (NYSE:NVTA) Ratings Coverage

In total 2 analysts cover Invitae (NYSE:NVTA). “Buy” rating has 2, “Sell” are 0, while 0 are “Hold”. (NYSE:NVTA) has 100% bullish analysts. 7 are the (NYSE:NVTA)’s ratings reports on Apr 16, 2019 according to StockzIntelligence Inc. On Wednesday, February 20 Benchmark maintained the shares of NVTA in report with “Buy” rating. On Wednesday, February 20 Oppenheimer maintained Invitae Corporation (NYSE:NVTA) rating. Oppenheimer has “Buy” rating and $21 target. On Wednesday, February 20 the stock of Invitae Corporation (NYSE:NVTA) has “Buy” rating given by J.P. Morgan. On Tuesday, February 26 the rating was maintained by Oppenheimer with “Buy”.

Invitae Corporation, a genetic information company, focuses on bringing comprehensive genetic information into mainstream medical practice to enhance the quality of healthcare in the United States, Canada, Israel, and internationally.The firm is valued at $2.18 billion. The firm processes DNA-containing samples, analyzes information about patient-specific genetic variation, and generates test reports for clinicians and their patients using an integrated portfolio of laboratory processes, software tools, and informatics capabilities.Last it reported negative earnings. It provides a diagnostic service comprising hundreds of genes for various genetic disorders associated with oncology, cardiology, neurology, pediatrics, and other rare disease areas.

For more Invitae Corporation (NYSE:NVTA) news brought out briefly go to: Seekingalpha.com, Fool.com, Investorplace.com, Investorplace.com or Benzinga.com. The titles are as follows: “Invitae Continues To Roll – Seeking Alpha” brought out on February 21, 2019, “About to Buy Penny Stocks? Look at These 3 Companies First – The Motley Fool” on March 18, 2019, “Twilio Stock Is a Must Buy on Any Market Correction – Investorplace.com” with a publish date: March 29, 2019, “5 Top Stock Trades for Monday: JD, NVTA, SBUX, SPOT, OXY – Investorplace.com” and the last “Park-Ohio Holdings Corp. (NASDAQ:PKOH), Invitae (NYSE:NVTA) – 4 Stocks Moving In Monday’s After-Hours Session – Benzinga” with publication date: March 04, 2019.